10 Telomere shortening has emerged as an important biomarker of aging. Longitudinal studies 11 consistently find that, although telomere length shortens over time on average, there is a subset of 12 individuals for whom telomere length is observed to increase. This apparent lengthening could 13 either be a genuine biological phenomenon, or simply due to measurement and sampling error. 14 Simons, Stulp and Nakagawa [Biogerontology 15: 99-103, 2014] recently proposed a statistical test 15 for detecting when the amount of apparent lengthening in a dataset exceeds that which should be 16 expected due to error, and thus indicating that genuine elongation may be operative in some 17 individuals. The test is however based on a restrictive assumption, namely that each individual's true 18 rate of telomere change is constant over time. It is not currently known whether this assumption is 19 true. Here we show, using simulated datasets, that with perfect measurement and large sample size, 20 the test has high power to detect true lengthening as long as the true rate of shortening is either 21 constant, or moderately stable, over time. If the true rate of lengthening varies randomly from year 22
Introduction 33
Telomere shortening in tissues such as blood has emerged as an important biomarker of ageing 34 (Müezzinler, Karina & Brenner, 2013) , predictor of future morbidity and mortality (Heidinger et al., 35 2012; Boonekamp et al., 2013; Rode, Nordestgaard & Bojesen, 2015) , and indicator of accumulated 36 adversity (Hau et al., 2015; Bateson, 2016) . Telomeres are repetitive DNA sequences at the end of 37 eukaryotic chromosomes that, on average at the population level, shorten with age. In longitudinal 38 studies, though, there is often a substantial fraction of the sample that shows an increase in 39 measured telomere length (Steenstrup et al., 2013b; Simons, Stulp & Nakagawa, 2014) . The 40 observation of apparent lengthening is potentially important, since it points to the possibility that a 41 marker of cellular ageing might under some circumstances be reversible in vivo. However, telomere 42 length cannot be measured with perfect precision. There is error variation both due to sampling 43 (heterogeneity in cells within an individual lead to variable estimates of that individual's average 44 telomere length), and measurement (laboratory assays do not produce identical results each time 45 even with the same sample). The existence of error variation means that the second of two 46 longitudinal samples may show a higher value than the first even if the true average telomere length 47 has not increased. Thus, it is possible that apparent telomere lengthening in a sample represents no 48 more than error (Steenstrup et al., 2013b; Bateson & Nettle, 2017) . 49
Simons, Stulp and Nakagawa (Simons, Stulp & Nakagawa, 2014 ; henceforth, SSN) recently proposed 50 a statistical test for detecting when there is more observed lengthening in a longitudinal sample than 51 should be expected under the hypothesis of error alone, and hence for inferring when true 52
lengthening is likely to be present in some subset of the sample. This is potentially a useful 53 innovation as it might allow resolution of whether apparent telomere lengthening over time in vivo 54 is a biologically real phenomenon or not. The test requires that each individual is measured at three 55 or more time points. To complete the test, a ratio of two variance estimators (henceforth, the F-56 ratio) is compared to an F-distribution, in a similar manner to the F-test familiar from ANOVA. Under 57 the null hypothesis (no true lengthening), the two estimators will be similar, the F-ratio will be close 58 to 1, and the p-value from comparing the statistic to the F-distribution with appropriate degrees of 59 freedom will be large (i.e. not significant). Under the alternative hypothesis (true lengthening is 60 present), the numerator will be substantially larger than the denominator, the F-ratio will be larger 61 than 1, and the p-value will therefore be small (considered significant by the usual convention when 62 p < 0.05). 63
The numerator of the F-ratio estimates the variability in the sample by a calculation based on the 64 number of individuals who have a higher measured telomere length at the final time point 65 compared to the first, and the magnitude of their apparent increase (SSN, equation 5; see SSN, 66 Appendix for derivation of this estimator). The denominator of the F-ratio estimates what under the 67 null hypothesis is the same variability, in a different way. It fits a separate regression line through 68
the points corresponding to the repeat measurements of each individual (so the number of 69 regression lines is equal to the number of individuals in the sample). For each of these lines, it 70 calculates the variance of the residuals, the deviations of the points from the fitted line. This is why 71 three measurement points are required: with just two points, the line goes through both and there 72 is no residual. Finally, the variability of the whole sample is estimated as the mean of the residual 73 variance from each of the separate individual regressions (see SSN, equations 1-3). 74
There is an important assumption involved in the specification of the denominator of the F-ratio 75 statistic, namely that each individual's telomeres truly change at a constant rate over time. Thus, any 76 deviation of the individual's successive measurement points from a straight line (either going up, 77 going down, or flat) can be taken to represent sampling or measurement error. However, it is not 78 currently known whether this assumption is empirically plausible or not. The pace of telomere 79
shortening has been linked to infection (Asghar et al., 2015) , adverse life events and stress ( Our objective was to estimate the likely power of the test to detect true lengthening when true 106 lengthening is in fact present. We kept the sample size in our simulated datasets at 10,000 107 individuals throughout, so as to be able to understand the power of the test even as sample size 108 becomes very large. 109
Methods 110
Our simulations are based on a computational model described formally in the Appendix, and 111 explored more fully in Bateson and Nettle (2017) . The R code to generate all the results that follow is 112 available as Supporting Online Material. The model assumes that telomere length is measured every 113
year, and it can be iterated to give as many years of data as required. 114
In the first stage of the model, the true telomere lengths at each time point for n = 10,000 115
individuals are generated. The baseline telomere lengths are drawn from a normal distribution with 116 mean 7,000 base pairs (bp) and standard deviation 700 bp. The second year's telomere lengths are 117 generated by subtracting a normally distributed random amount with mean 30 bp and standard 118 deviation 50 bp. This means that although the average telomere length shortens from baseline to 119
the second year, some individuals truly lengthen. For example, an individual whose attrition is one 120 standard deviation from the mean in the positive direction actually experiences lengthening of 20 Bateson & Nettle, 2017). Note that measurement error is implemented as a fixed standard deviation 143 around the true length, and not as a coefficient of variation as in our previous paper (Bateson & 144 Nettle, 2017). Recent evidence suggests that the assumption implicit in the construction of a 145 coefficient of variation (that measurement error is proportional to the telomere length measured) 146 may not hold for telomere measurement, at least when done by qPCR (Verhulst et al., 2015) . 147
We used the model to generate one hundred datasets at each combination of: two to eleven years 148 of follow-up; and autocorrelations of r = 1, r = 0.5 and r = 0. All of these datasets contained true 149 telomere lengthening, though the proportion of true lengtheners varied as functions of both length 150 of follow-up and autocorrelation (Bateson & Nettle, 2017) . For each dataset, we calculated the F-151 ratio statistic using the code provided by SSN. We investigated, for each combination of years of 152 follow-up and r: first, how many true lengtheners there were in each dataset; and second, how many 153 of the possible 100 F-ratio tests were significant by the conventional criterion of p < 0.05. 154
Results 155
In figure 1 was not met (r = 0.5 and r = 0), the test always returned a non-significant result. Finally, we 192 considered measurement error equal to a standard deviation of 560 bp. Here, the test always 193 returned a non-significant result, although substantial fractions of the population exhibited true 194 lengthening. 195
Discussion 196
We considered the performance of the F-ratio test proposed by SSN on simulated longitudinal 197 datasets, under different scenarios for the nature of the true telomere dynamics and the magnitude 198 of measurement error, where there was a non-zero and known proportion of true telomere 199 lengtheners, and the sample size was very large. Ideally the test should have been significant in all or 200 the vast majority of cases, particularly those where the proportion of true lengtheners was 201 substantial. We found that, whilst the test correctly detected lengthening under two of our nine 202 scenarios, for the remainder, it either always or usually returned a type-II error. That is, it led to the 203 acceptance of a null hypothesis (no true lengthening) that should have been be rejected. 204
Our first conclusion is that measurement error at the levels that have been reported in the human 205 literature reduces the power of the proposed test to a low level. Under our smaller and larger non-206 zero measurement-error scenarios, the test returned a non-significant result almost all of the time. 207
This was despite our using samples (10,000 individuals) that are at the upper end of the size range 208 studied in practice by empiricists. The finding that increased measurement error reduces the test's 209 power accords with the power simulations presented by SSN. They found that power was good as 210 long as the standard deviation of true attrition was larger than the standard deviation due to 211 measurement error (see SSN, figure 1). We agree, but would argue that the standard deviation of 212 attrition is generally much smaller than the standard deviation due to measurement error in 213 practice. For humans, the best empirical estimates are that the standard deviation of annual true 214 telomere attrition is of the order 14 -53 bp/year for humans (Aviv et variation. Telomere dynamics are likely to vary between species, and so different models of how 253 telomeres change may be appropriate to different systems. Our simulations with moderate but 254 imperfect individual consistency generated the consistency through an autoregressive process of 255 order one; this is not the only possible method, and may not be the most appropriate. Thus, we 256 would appeal to the field to conduct large longitudinal studies with more than two measurement 257 time points. As well as shedding light on the appropriateness of SSN's true-constant-rate 258 assumption, this would help us to build better process models of how telomeres change, and hence 259 to derive robust statistical models against which empirical data can be compared. 
